MedKoo Cat#: 145210 | Name: DSP-0390

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DSP-0390 is an oral emopamil binding protein (EBP) inhibitor. DSP-0390 can potently inhibit EBP, an enzyme in one of the last and crucial steps of cholesterol biosynthesis. By inhibiting de novo cholesterol synthesis, cytotoxicity can be induced more selectively against hyperproliferative GBM cells. DSP-0390 has shown significant antitumor activity in orthotopic xenograft models of human GBM.

Chemical Structure

DSP-0390
DSP-0390
CAS#2376765-57-8

Theoretical Analysis

MedKoo Cat#: 145210

Name: DSP-0390

CAS#: 2376765-57-8

Chemical Formula: C23H30ClN3O2

Exact Mass: 415.2027

Molecular Weight: 415.96

Elemental Analysis: C, 66.41; H, 7.27; Cl, 8.52; N, 10.10; O, 7.69

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
DSP-0390; DSP0390; DSP 0390;
IUPAC/Chemical Name
(4a'R,10b'R)-1-(2-(1H-imidazol-1-yl)ethyl)-8'-chloro-5',5'-dimethyl-4a',10b'-dihydro-2'H,4'H,5'H-spiro[piperidine-4,3'-pyrano[3,2-c]chromene]
InChi Key
QKAZUVQTHFXMLS-CTNGQTDRSA-N
InChi Code
1S/C23H30ClN3O2/c1-22(2)19-14-23(5-8-26(9-6-23)11-12-27-10-7-25-16-27)15-28-21(19)18-4-3-17(24)13-20(18)29-22/h3-4,7,10,13,16,19,21H,5-6,8-9,11-12,14-15H2,1-2H3/t19-,21+/m1/s1
SMILES Code
[H][C@@]12OCC3(CCN(CCN4C=CN=C4)CC3)C[C@@]1([H])C(C)(C)OC5=C2C=CC(Cl)=C5
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
The brain’s cells are fully dependent on their own de novo biosynthesis of cholesterol as the blood-brain barrier prevents its uptake from the circulation. In normal glial cells, proper regulation of cholesterol synthesis depends on its cell density and is turned off when the cell density exceeds a certain level. On the other hand, gliomas maintain high levels of cholesterol synthesis to support abnormal growth under any condition. Upregulation of cholesterol synthesis genes is associated with decreased survival in patients with glioblastoma (GBM). Therefore, gliomas are potentially sensitive to cholesterol synthesis inhibition.

Preparing Stock Solutions

The following data is based on the product molecular weight 415.96 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL